Amanda Schellenberger

Ms. Amanda Schellenberger


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2015 in Molecules
Verified
Journal Article
Open access
PDF file
ASAmanda Schellenberger
Amanda Schellenberger
ASAmanda Schellenberger
Amanda Schellenberger
DGDouglas C. Goodwin
Douglas C. Goodwin
NFNgolui Rene Fuanta
Ngolui Rene Fuanta
BTBabu Tekwani
Babu Tekwani
ACAngela Calderon
Angela Calderon
The growing resistance to current antimalarial drugs is a major concern for global public health. The pressing need for new antimalarials has led to an increase in research focused on the Plasmodium parasites that cause human malaria. Thioredoxin reductase (TrxR), an enzyme needed to maintain redox equilibrium in Plasmodium species, is a promising target for new antimalarials. This review paper provides an overview of the structure and function of TrxR, discusses similarities and differences between the thioredoxin reductases (TrxRs) of different Plasmodium species and the human forms of the enzyme, gives an overview of modeling Plasmodium infections in animals, and suggests the role of Trx functions in antimalarial drug resistance. TrxR of Plasmodium falciparum is a central focus of this paper since it is the only Plasmodium TrxR that has been crystallized and P. falciparum is the species that causes most malaria cases. It is anticipated that the information summarized here will give insight and stimulate new directions in which research might be most beneficial.